Garcia-Manau, P., Mendoza, M., Bonacina, E., Martin-Alonso, R., Martin, L., Palacios, A., . . . Carreras, E. (2022). The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial.
Citación estilo ChicagoGarcia-Manau, P., et al. The Fetal Growth Restriction At Term Managed By Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial. 2022.
Cita MLAGarcia-Manau, P., et al. The Fetal Growth Restriction At Term Managed By Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial. 2022.